Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria
暂无分享,去创建一个
Sumana Chakravarty | Stephen L. Hoffman | S. Hoffman | C. Plowe | R. Edelman | K. Lyke | P. Billingsley | T. Richie | B. Sim | M. Sedegah | S. Chakravarty | J. Epstein | M. Laurens | A. Gunasekera | E. James | S. Reyes | A. Ahumada | M. Loyevsky | A. Richman | Minglin Li | Tao Li | R. Stafford | Christopher V. Plowe | Peter F. Billingsley | Eric James | Adam Richman | Mark Loyevsky | Tao Li | Anusha Gunasekera | Rana Chattopadhyay | Minglin Li | Richard Stafford | Adriana Ahumada | Judith E. Epstein | Martha Sedegah | Sharina Reyes | Thomas L. Richie | Kirsten E. Lyke | Robert Edelman | Matthew Laurens | B. Kim Lee Sim | R. Chattopadhyay | S. Chakravarty | Stephen L. Hoffman | Eric R. James | Adam Richman | Rana Chattopadhyay | Richard Stafford | Adriana Ahumada | R. Edelman | B. Sim
[1] W. Ripley Ballou. Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine. , 2007, Microbes and infection.
[2] M. Toner,et al. Further optimization of mouse spermatozoa evaporative drying techniques. , 2009, Cryobiology.
[3] M. Mota,et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Lagrange. [Preventive vaccination against tuberculosis: BCG]. , 1984, Annales de pediatrie.
[5] S. Hoffman,et al. Pre-erythrocytic and asexual erythrocytic stage whole-organism malaria vaccines , 2010 .
[6] S. Kummar,et al. Non-small-cell lung cancer vaccine therapy: a concise review. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Moreno,et al. Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. , 1991, International immunology.
[8] S. Calderwood,et al. Cholera vaccines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] S. Kappe,et al. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. , 2007, The Journal of infectious diseases.
[10] S. Kappe,et al. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine , 2005, Nature.
[11] E. Nardin. T cell responses in a sporozoite-immunized human volunteer and a chimpanzee. , 1990, Immunology letters.
[12] S. Hay,et al. The decline in paediatric malaria admissions on the coast of Kenya , 2007, Malaria Journal.
[13] D. Clyde,et al. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. , 1975, The American journal of tropical medicine and hygiene.
[14] R. Miller,et al. Specificity of protection of man immunized against sporozoite‐induced falciparum malaria , 1973, The American journal of the medical sciences.
[15] James A. Hutchinson,et al. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate‐pulsed cells: a phase I/II study , 2004, BJU international.
[16] O. Sabot,et al. A new global malaria eradication strategy , 2008, The Lancet.
[17] J. Vanderberg,et al. Immunization of man against sporozite-induced falciparum malaria , 1973, The American journal of the medical sciences.
[18] J. Barnwell,et al. Pre-erythrocytic stage malaria vaccines: time for a change in path. , 2007, Current opinion in microbiology.
[19] V. Nussenzweig,et al. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. , 1987, Journal of immunology.
[20] M. Pikal,et al. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody. , 2007, Journal of pharmaceutical sciences.
[21] S. Hoffman,et al. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. , 1995, Journal of immunology.
[22] Joel S. Freundlich,et al. The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. , 2008, Cell host & microbe.
[23] G Losonsky,et al. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. , 1993, The Journal of infectious diseases.
[24] Rajendra Maharaj,et al. Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland. , 2007, The American journal of tropical medicine and hygiene.
[25] K. Matuschewski,et al. A Sporozoite Asparagine-Rich Protein Controls Initiation of Plasmodium Liver Stage Development , 2008, PLoS pathogens.
[26] I. Coppens,et al. Plasmodium yoelii Sporozoites with Simultaneous Deletion of P52 and P36 Are Completely Attenuated and Confer Sterile Immunity against Infection , 2007, Infection and Immunity.
[27] M. Levine,et al. Progress in vaccines against typhoid fever. , 1989, Reviews of infectious diseases.
[28] L. Purcell,et al. Chemical Attenuation of Plasmodium berghei Sporozoites Induces Sterile Immunity in Mice , 2008, Infection and Immunity.
[29] S. Hoffman,et al. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine , 2003, Journal of Experimental Biology.
[30] Usman Abdulmumini,et al. A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods , 2006, Malaria Journal.
[31] K. Sell,et al. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. , 1979, Bulletin of the World Health Organization.
[32] A. Aly,et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design , 2009, Proceedings of the National Academy of Sciences.
[33] Patricia De la Vega,et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.
[34] K. Sell,et al. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. , 1974, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[35] S. Hoffman,et al. The Complexity of Protective Immunity Against Liver-Stage Malaria1 2 , 2000, The Journal of Immunology.
[36] C. Plowe,et al. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’ , 2009, Parasite immunology.
[37] J. Vanderberg,et al. Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.
[38] B. Bloom,et al. Drying a tuberculosis vaccine without freezing , 2007, Proceedings of the National Academy of Sciences.
[39] A. Moreno,et al. CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. , 1993, Journal of immunology.
[40] S. Kappe,et al. Conserved Protective Mechanisms in Radiation and Genetically Attenuated uis3(-) and uis4(-) Plasmodium Sporozoites , 2009, PloS one.
[41] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.
[42] K. Rieckmann,et al. Human immunization with attenuated sporozoites. , 1990, Bulletin of the World Health Organization.
[43] P. Barr,et al. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. , 1990, Bulletin of the World Health Organization.
[44] S. Hoffman,et al. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Hoffman,et al. Gene Disruption of Plasmodium falciparum p52 Results in Attenuation of Malaria Liver Stage Development in Cultured Primary Human Hepatocytes , 2008, PloS one.
[46] S. Hoffman,et al. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2 , 1995, The Journal of experimental medicine.
[47] P. Caspers,et al. Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. , 1989, Science.
[48] L. Purcell,et al. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. , 2008, Vaccine.
[49] John Sidney,et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Domingo,et al. Smallpox: The Triumph over the Most Terrible of the Ministers of Death , 1997, Annals of Internal Medicine.
[51] S. Hoffman,et al. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine. , 2009, Vaccine.
[52] G. Di Giulio,et al. Live immunization against East Coast fever--current status. , 2009, Trends in parasitology.
[53] D. Clyde. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. , 1990, Bulletin of the World Health Organization.
[54] Abdullah S Ali,et al. Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in Zanzibar , 2007, PLoS medicine.
[55] S. Hoffman,et al. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. , 2007, The Journal of infectious diseases.
[56] S. Hoffman,et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. , 1993, The American journal of tropical medicine and hygiene.
[57] I. Schneider,et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. , 1995, Journal of immunology.
[58] J. Vanderberg,et al. Direct Microscopic Quantification of Dynamics of Plasmodium berghei Sporozoite Transmission from Mosquitoes to Mice , 2007, Infection and Immunity.
[59] F. Jongejan,et al. Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity. , 2007, Trends in parasitology.
[60] D. Clyde,et al. Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. , 1977, Experimental parasitology.
[61] D. Herrington,et al. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. , 1991, The American journal of tropical medicine and hygiene.
[62] S. Kappe,et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] S. Hoffman,et al. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. , 2009, The Journal of infectious diseases.
[64] James M. Wilson,et al. Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines , 2002, The Journal of experimental medicine.
[65] M. Mota,et al. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. , 2007, International journal for parasitology.
[66] M. Good,et al. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. , 1988, Proceedings of the National Academy of Sciences of the United States of America.